PER 4.29% 6.7¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-802

  1. 93 Posts.
    lightbulb Created with Sketch. 20
    In the Serepta market raise of 500m was an additional option to raise up to another 75m.

    could the 500m be up front payment then the 75m cover the EMA trial plus a future combined trial ?

    I know people are not feeling confident on we will get the 500m but this is in the range Diamond has been mentioning in the past as 'market comparison'

    Does anyone have a list of top 20 shareholders ? I'd be interested to see if there has been much change of late
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.